Research perspective: Cancer prevention with rapamycin
A new research perspective was published in Oncotarget entitled "Cancer prevention with rapamycin."
Apr 17, 2023
0
1
A new research perspective was published in Oncotarget entitled "Cancer prevention with rapamycin."
Apr 17, 2023
0
1
Research from Johns Hopkins Kimmel Cancer Center experts revealed a type of RNA, previously considered to be "junk," that may help doctors distinguish and treat a subgroup of patients with medulloblastoma.
Mar 23, 2023
0
27
The ability of a cell to divide, to proliferate, is essential for life and gives rise to the formation of complex organisms from a single cell. It also allows the replacement of used cells from a limited number of "stem" ...
Mar 17, 2023
0
88
A new study published in the journal Cell Death & Disease by researchers at the University of Alabama at Birmingham has identified a potential therapeutic target for triple-negative breast cancer, or TNBC, an aggressive treatment-resistant ...
Feb 21, 2023
0
23
Cancer is a disease driven by gene mutations. These mutated genes in cancer fall into two major categories: tumor suppressors and oncogenes. Mutations in tumor suppressor genes can allow tumors to grow unchecked—a case ...
Feb 10, 2023
0
62
A study led by Consejo Superior de Investigaciones CientĂficas (CSIC) has demonstrated the efficiency of an ultrasound radiation-based therapy on the inhibition of cancer cell motion in pancreas cancer models. This work, ...
Jan 30, 2023
0
23
Chemotherapy is a commonly used regimen for cancer treatment, but it is also a double-edged sword. While the drugs are highly effective at killing cancer cells, they are also notorious for killing healthy cells in the body. ...
Jan 24, 2023
0
51
A product of a freshwater single-celled green algae called Euglena gracilis may enhance skin regeneration to speed up wound healing, according to new research published in Advanced Materials Interfaces.
Jan 11, 2023
0
15
A team of researchers with member affiliations across the U.S. and Canada has found evidence of multiple recurrent, repeat expansions in human cancer genomes. In their paper published in the journal Nature, the group describes ...
The Shin Kaneko laboratory at CiRA has developed a method to generate CAR-T cells from iPS cells (iCAR-T cells) that possess vastly improved anti-tumor activity in a mouse model of solid tumors.
Dec 13, 2022
0
8